CONTACTStaffCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Treating genital herpes may slow the progression of the AIDS virus in those infected with both viruses, researchers reported on Wednesday.
The test involving 140 women in the West African country of Burkina Faso found that when herpes was being treated with 500 milligrams of the drug valacyclovir twice daily for three months, the women were less likely to shed, or spread, HIV.
In addition, the treatment reduced HIV levels in the blood, the research group led by Nicolas Nagot of the London School of Hygiene and Tropical Medicine found.
The drug's effect increased steadily over time, so "a longer duration of treatment might have led to an even greater reduction" in the amount of HIV detected, the researchers conclude in the New England Journal of Medicine.
Valacyclovir, made and sold by GlaxoSmithKline under the brand name Valtrex, is one of several drugs that can treat herpes.
Among people already infected with HIV, up to 70% in Europe and 90% in Africa also carry the virus for genital herpes, HSV-2.
Until now, doctors have placed less emphasis on genital herpes because it is not as dangerous as HIV.
The new study may change that, said Philip Keiser, who runs the AIDS clinic at the University of Texas Southwestern Medical Center in Dallas. Keiser was not connected with the research.
With existing HIV treatments, "the best we can do right now is to get 70% to 80% of patients to the point where we totally suppress the virus. That means that 20% to 30%, right off the bat, will not do well," he said in a telephone interview.
He said the findings would change the way he treats patients who have both HIV and herpes.
"I'll be more aggressive in treating their herpes and keep them on the valacyclovir for a long time," Keiser said. "This may be one of those small refinements that add something to that (success rate) and help our patients do better over the long haul." (Gene Emery, Reuters)
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Meet all 37 of the queer women in this season's WNBA
April 17 2024 11:24 AM
Here are the 15 gayest travel destinations in the world: report
March 26 2024 9:23 AM
21+ steamy photos of Scotland’s finest gay men in Elska Glasgow
February 01 2024 10:07 PM
More Than 50 of Our Favorite LGBTQ+ Moms
May 12 2024 11:44 AM
Conjoined twins Lori Schappell and trans man George Schappell dead at 62
April 27 2024 6:13 PM
Latest Stories
Kamala Harris rides wave of Democratic energy at kickoff event in Wisconsin
July 23 2024 3:36 PM
'Devastated:' A six-week abortion ban will go into effect in Iowa next week
July 23 2024 2:28 PM
Four hours, 44,000 Black women, and one Zoom call
July 23 2024 2:17 PM
Record 1.2 million people show out for Cologne’s Pride parade
July 23 2024 10:51 AM
Here's how far-right activist Leonard Leo helped fund Bud Light boycott
July 23 2024 10:27 AM
Elon Musk’s comments about his trans daughter prove why she doesn’t speak to him
July 23 2024 9:16 AM
Nancy Pelosi endorses Kamala Harris for president
July 22 2024 4:07 PM